Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

about

Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa ST175 in a Hollow-Fiber Infection Model.

P2860

Q40056971-C122BA2C-24AD-440B-A14A-016E9045DC0A Q51741113-409779AB-FC2C-45DE-AFF9-DBF9CCD872BC

P2860

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

Item

http://www.wikidata.org/entity/Q40882363

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

@en

type

Item

label

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

@en

prefLabel

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

@en

P1476

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

@en

P2093

A Oliver

http://www.w3.org/2001/XMLSchema#string

A Vitkauskiene

http://www.w3.org/2001/XMLSchema#string

G Mikucionyte

http://www.w3.org/2001/XMLSchema#string

L Zamorano

http://www.w3.org/2001/XMLSchema#string

X Mulet

http://www.w3.org/2001/XMLSchema#string

P2860

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains

Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Pseudomonas aeruginosa: resistance to the max

Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.

Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.

Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa.

P2888

s10096-015-2529-0

P304

195-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10096-015-2529-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Juan

Carla López-Causapé

P577

2015-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001300909

http://www.w3.org/2001/XMLSchema#string

P698

26638216

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

about

P2860

P2860

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921